| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-153 |
Sentence |
denotes |
Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. |
| TextSentencer_T2 |
154-164 |
Sentence |
denotes |
OBJECTIVE: |
| TextSentencer_T3 |
165-479 |
Sentence |
denotes |
We attempted to compare the use of low-dose heparin with a standard dose of 40 mg prednisone daily (both plus low-dose aspirin) for treatment of pregnant women with antiphospholipid antibody-associated recurrent fetal loss with respect to maternal and perinatal morbidity and efficacy in prevention of fetal death. |
| TextSentencer_T4 |
480-493 |
Sentence |
denotes |
STUDY DESIGN: |
| TextSentencer_T5 |
494-546 |
Sentence |
denotes |
A multicenter randomized trial included 20 patients. |
| TextSentencer_T6 |
547-707 |
Sentence |
denotes |
Generalizability of results from randomized patients was evaluated by means of additional data from 13 women refusing and 12 women ineligible for randomization. |
| TextSentencer_T7 |
708-834 |
Sentence |
denotes |
Data from study groups were compared with Fisher's exact test, and generalizability was evaluated with a chi 2 test for trend. |
| TextSentencer_T8 |
835-843 |
Sentence |
denotes |
RESULTS: |
| TextSentencer_T9 |
844-1069 |
Sentence |
denotes |
Live birth rates were the same (75%) with either treatment, but "serious" maternal morbidity and the frequency of preterm delivery were significantly higher among women randomly assigned to prednisone (p = 0.02 vs p = 0.006). |
| TextSentencer_T10 |
1070-1197 |
Sentence |
denotes |
Preterm delivery among prednisone-treated women was usually associated with premature rupture of the membranes or preeclampsia. |
| TextSentencer_T11 |
1198-1305 |
Sentence |
denotes |
These results could be generalized to the other groups of women ascertained during the course of the study. |
| TextSentencer_T12 |
1306-1318 |
Sentence |
denotes |
CONCLUSIONS: |
| TextSentencer_T13 |
1319-1460 |
Sentence |
denotes |
Low-dose heparin should be preferred to prednisone when treatment is indicated for high-risk pregnant women with antiphospholipid antibodies. |
| T1 |
0-153 |
Sentence |
denotes |
Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. |
| T2 |
154-164 |
Sentence |
denotes |
OBJECTIVE: |
| T3 |
165-479 |
Sentence |
denotes |
We attempted to compare the use of low-dose heparin with a standard dose of 40 mg prednisone daily (both plus low-dose aspirin) for treatment of pregnant women with antiphospholipid antibody-associated recurrent fetal loss with respect to maternal and perinatal morbidity and efficacy in prevention of fetal death. |
| T4 |
480-493 |
Sentence |
denotes |
STUDY DESIGN: |
| T5 |
494-546 |
Sentence |
denotes |
A multicenter randomized trial included 20 patients. |
| T6 |
547-707 |
Sentence |
denotes |
Generalizability of results from randomized patients was evaluated by means of additional data from 13 women refusing and 12 women ineligible for randomization. |
| T7 |
708-834 |
Sentence |
denotes |
Data from study groups were compared with Fisher's exact test, and generalizability was evaluated with a chi 2 test for trend. |
| T8 |
835-843 |
Sentence |
denotes |
RESULTS: |
| T9 |
844-1069 |
Sentence |
denotes |
Live birth rates were the same (75%) with either treatment, but "serious" maternal morbidity and the frequency of preterm delivery were significantly higher among women randomly assigned to prednisone (p = 0.02 vs p = 0.006). |
| T10 |
1070-1197 |
Sentence |
denotes |
Preterm delivery among prednisone-treated women was usually associated with premature rupture of the membranes or preeclampsia. |
| T11 |
1198-1305 |
Sentence |
denotes |
These results could be generalized to the other groups of women ascertained during the course of the study. |
| T12 |
1306-1318 |
Sentence |
denotes |
CONCLUSIONS: |
| T13 |
1319-1460 |
Sentence |
denotes |
Low-dose heparin should be preferred to prednisone when treatment is indicated for high-risk pregnant women with antiphospholipid antibodies. |